Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2007

01-01-2007 | PRECLINICAL STUDY

Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients

Authors: Christian Schindlbeck, Udo Jeschke, Sandra Schulze, Uwe Karsten, Wolfgang Janni, Brigitte Rack, Stan Krajewski, Harald Sommer, Klaus Friese

Published in: Breast Cancer Research and Treatment | Issue 1/2007

Login to get access
Metadata
Title
Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
Authors
Christian Schindlbeck
Udo Jeschke
Sandra Schulze
Uwe Karsten
Wolfgang Janni
Brigitte Rack
Stan Krajewski
Harald Sommer
Klaus Friese
Publication date
01-01-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9271-3

Other articles of this Issue 1/2007

Breast Cancer Research and Treatment 1/2007 Go to the issue

Clinical trial

Women’s Anxieties Caused by False Positives in Mammography Screening: A Contingent Valuation Survey

Epidemiology

A Study on the Association of Cytochrome-P450 1A1 Polymorphism and Breast Cancer Risk in North Indian Women

Letter to the Editor

Fulvestrant in Advanced Male Breast Cancer

PRECLINICAL STUDY

Differential Effects of Omega-3 and Omega-6 fatty Acids on Gene Expression in Breast Cancer Cells

Obituary

Obituary

Pre clinical Study

A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits